CTGF and TGF-β Interaction in Fibrosis
Author Information
Author(s): Wang Qingjian, Usinger William, Nichols Blake, Gray Julia, Xu Leon, Seeley Todd W, Brenner Mitch, Guo Guangjie, Zhang Weihua, Oliver Noelynn, Lin Al, Yeowell David
Primary Institution: FibroGen Inc.
Hypothesis
The study examines the cooperative interaction of CTGF and TGF-β in fibrotic disease models.
Conclusion
CTGF and TGF-β work together to cause tissue fibrosis, and blocking CTGF with FG-3019 can reduce this fibrosis.
Supporting Evidence
- CTGF and TGF-β2 together caused significant fibrosis in multiple organs.
- Blocking CTGF with FG-3019 reduced fibrosis in all tested models.
- Fibrosis was not observed when either CTGF or TGF-β2 was administered alone.
Takeaway
CTGF and TGF-β are like two friends that help each other make scars in the body, and a special medicine can help stop them from doing that.
Methodology
The study used three murine models of fibrosis and administered CTGF and TGF-β2 to observe fibrotic responses.
Potential Biases
Potential bias due to all authors being affiliated with FibroGen.
Limitations
The study was limited to animal models, and the effects in humans may differ.
Participant Demographics
Male Swiss Webster and C57BL/6 mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website